Literature DB >> 762657

Pharmacokinetics of naloxone and naltrexone in the dog.

N L Pace, R G Parrish, M M Lieberman, K C Wong, R A Blatnick.   

Abstract

The serum kinetics of 5 mg/kg of i. v. naloxone or naltrexone were studied in each of two groups of five dogs; serum samples were obtained from 2 min to 2 hr after injection. Serum concentrations were determined by radioimmunoassay. Serum levels of both naloxone and naltrexone fell rapidly; serum half-life during the elimination phase was 71.2 +/- 8.9 min (mean +/- S.E.) for naloxone and 85.1 +/- 9.0 min (mean +/- S.E.) for naltrexone. Although human and dog kinetics are similar for naloxone, naltrexone is long-acting in man, but is quickly dissipated in the dog.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 762657

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Effect of naloxone and morphine on various forms of memory in the rat: possible role of engogenous opiate mechanisms in memory consolidation.

Authors:  I Izquierdo
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

2.  Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone.

Authors:  Sarita Naik; Renata Belfort-DeAguiar; Anne-Sophie Sejling; Barbara Szepietowska; Robert S Sherwin
Journal:  Diabetes Obes Metab       Date:  2017-02-17       Impact factor: 6.577

3.  Naloxone and nalmefene absorption delivered by hollow microneedles compared to intramuscular injection.

Authors:  Mark G Papich; Roger J Narayan
Journal:  Drug Deliv Transl Res       Date:  2021-11-24       Impact factor: 4.617

4.  Influence of the optical isomers (+)- and (-)-naloxone on beating frequency, contractile force and action potentials of guinea-pig isolated cardiac preparations.

Authors:  H Brasch
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

5.  Effects of intravascular volume expansion on the cardiovascular response to naloxone in a canine model of severe endotoxin shock.

Authors:  S F Evans; C J Hinds; J G Varley
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

6.  [Oral administration of slow-release naloxone for prevention of constipation but not analgesia following oral morphine.].

Authors:  I Jurna; J Baldauf
Journal:  Schmerz       Date:  1993-12       Impact factor: 1.107

7.  Disposition of naltrexone after intravenous bolus administration in Wistar rats, low-alcohol-drinking rats and high-alcohol-drinking rats.

Authors:  Emmanuel O Akala; Hu Wang; Adedayo Adedoyin
Journal:  Neuropsychobiology       Date:  2008-10-03       Impact factor: 2.328

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.